• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Percutaneous Coronary Intervention for Tortuous Left Anterior Descending Artery with Bioresorbable Vascular Scaffold via the Transradial Approach.经桡动脉途径使用生物可吸收血管支架对迂曲左前降支进行经皮冠状动脉介入治疗。
Acta Cardiol Sin. 2018 Nov;34(6):530-532. doi: 10.6515/ACS.201811_34(6).20180818B.
2
Bioresorbable Vascular Scaffold Stent Delivered to Tortuous Lesions by Using the "Five-in-Six" System.使用“六进五”系统将生物可吸收血管支架输送至迂曲病变处。
Acta Cardiol Sin. 2017 Nov;33(6):672-675. doi: 10.6515/ACS20170413A.
3
The utility of extension catheters in transradial percutaneous coronary intervention.延长导管在经桡动脉经皮冠状动脉介入治疗中的应用
J Invasive Cardiol. 2015 Jan;27(1):28-32.
4
Very late bioresorbable scaffold thrombosis and reoccurrence of dissection two years later chronic total occlusion recanalization of the left anterior descending artery.非常晚期生物可吸收支架血栓形成以及两年后再发夹层，左前降支慢性完全闭塞再通。
World J Cardiol. 2017 Aug 26;9(8):710-714. doi: 10.4330/wjc.v9.i8.710.
5
Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ABSORB III Trial.经皮冠状动脉介入治疗患者中生物可吸收血管支架与依维莫司洗脱支架的经济学结局：ABSORB III 试验 1 年结果。
JACC Cardiovasc Interv. 2017 Apr 24;10(8):774-782. doi: 10.1016/j.jcin.2017.01.022.
6
Incidence and significance of side branch occlusions following bioresorbable scaffold implantation for long left anterior descending artery lesions.生物可吸收支架植入治疗左前降支长病变后侧支闭塞的发生率及意义
Int J Cardiol. 2016 Nov 1;222:674-675. doi: 10.1016/j.ijcard.2016.08.060. Epub 2016 Aug 4.
7
The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment.生物可吸收血管支架Absorb BVS®在稳定型冠状动脉疾病患者中的应用：特别关注混合生物可吸收血管支架和药物洗脱支架治疗的一年结果。
Kardiol Pol. 2016;74(7):627-33. doi: 10.5603/KP.a2015.0250. Epub 2016 Jan 18.
8
Platelet counts on admission affect coronary flow, myocardial perfusion and left ventricular systolic function after primary percutaneous coronary intervention.入院时的血小板计数会影响经皮冠状动脉介入治疗后的冠状动脉血流、心肌灌注和左心室收缩功能。
Eur Heart J Acute Cardiovasc Care. 2017 Oct;6(7):632-639. doi: 10.1177/2048872616643690. Epub 2016 Apr 11.
9
Retrograde percutaneous recanalization of chronic total occlusion of the left anterior descending artery through an extremely tortuous right ventricular branch.经极度迂曲的右心室分支对左前降支慢性完全闭塞病变进行逆向经皮再通术。
Cardiovasc Interv Ther. 2012 Sep;27(3):210-3. doi: 10.1007/s12928-012-0110-7. Epub 2012 Jun 19.
10
Immediate results of percutaneous coronary intervention for unprotected left main coronary artery stenoses: transradial versus transfemoral approach.经皮冠状动脉介入治疗无保护左主干冠状动脉狭窄的即刻结果：桡动脉与股动脉入路对比
Chang Gung Med J. 2008 Mar-Apr;31(2):190-200.

引用本文的文献

1
Efficacy and Biosafety of a New Bioresorbable Vascular Scaffold Covered with Biodegradable Film in Rabbits: An In Vivo Study.新型可生物降解薄膜覆盖可生物吸收血管支架在兔体内的有效性及生物安全性：一项体内研究
Acta Cardiol Sin. 2020 Nov;36(6):660-666. doi: 10.6515/ACS.202011_36(6).20200421B.
2
Use of Intracoronary Imaging for Optimization of Bioresorbable Vascular Scaffold Implantation and Left Main Disease.冠状动脉内成像在生物可吸收血管支架植入及左主干病变优化中的应用
Acta Cardiol Sin. 2019 Jul;35(4):437-438. doi: 10.6515/ACS.201907_35(4).20190306A.

本文引用的文献

1
Thirty-Day and One-Year Clinical Outcomes of Bioresorbable Vascular Scaffold Implantation: A Single-Center Experience.生物可吸收血管支架植入术的30天和1年临床结果：单中心经验
Acta Cardiol Sin. 2017 Nov;33(6):614-623. doi: 10.6515/ACS20170714A.
2
Everolimus-Eluting Bioresorbable Vascular Scaffold in Real World Practice - A Single Center Experience.依维莫司洗脱生物可吸收血管支架在实际临床中的应用——单中心经验
Acta Cardiol Sin. 2017 May;33(3):250-257. doi: 10.6515/acs20160901a.
3
Bioresorbable scaffold - A magic bullet for the treatment of coronary artery disease?生物可吸收支架——治疗冠状动脉疾病的神奇疗法？
Int J Cardiol. 2016 Jul 15;215:47-59. doi: 10.1016/j.ijcard.2016.04.027. Epub 2016 Apr 12.
4
Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users : A position statement on the use of bioresorbable vascular scaffolds in the Netherlands.经皮冠状动脉介入治疗中生物可吸收血管支架的合理应用：有经验用户的推荐意见：荷兰关于生物可吸收血管支架应用的立场声明。
Neth Heart J. 2015 Mar;23(3):161-5. doi: 10.1007/s12471-015-0651-3.
5
Going around the bend: deep inspiration facilitates difficult stent delivery in the native coronary arteries.转弯：深吸气有助于在自身冠状动脉中进行困难的支架植入。
Tex Heart Inst J. 2011;38(3):270-4.
6
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.第二代生物可吸收依维莫司药物洗脱血管支架治疗冠状动脉原发狭窄的临床和影像学 6 个月随访结果。
Circulation. 2010 Nov 30;122(22):2301-12. doi: 10.1161/CIRCULATIONAHA.110.970772. Epub 2010 Nov 15.

Percutaneous Coronary Intervention for Tortuous Left Anterior Descending Artery with Bioresorbable Vascular Scaffold via the Transradial Approach.

作者信息

Lee Wei-Chieh, Fang Hsiu-Yu, Wu Chiung-Jen

机构信息

Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.

出版信息

Acta Cardiol Sin. 2018 Nov;34(6):530-532. doi: 10.6515/ACS.201811_34(6).20180818B.

DOI:10.6515/ACS.201811_34(6).20180818B
PMID:30449995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6236573/
Abstract
摘要